Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

Clinical trial NCT00869778 · COMPLETED

Trial details

NCT number: NCT00869778
Sponsor: Chongqing Jiachen Biotechnology Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2009-04-01
Primary completion: 2011-11-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.